1. Home
  2. Research
  3. Research Groups
  4. Diabetes, Obesity and Human Reproduction

Diabetes, Obesity and Human Reproduction

Search for publications

Only original articles, editorials, guidelines.

  • Lobo R, Angulo A, Muñoz A, Colli E, Escobar-Morreale HF, Luque-Ramírez M, Zatik J, Regidor PA.

    Oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen for polycystic ovary syndrome-associated hirsutism: a double-blind, randomised, placebo-controlled trial.

    Eclinicalmedicine . 90: 103594-103594.

    [doi:10.1016/j.eclinm.2025.103594]

  • Luque-Ramírez M, Martínez-García MÁ, Insenser M, Quintero-Tobar A, de Lope Quiñones S, Nattero-Chávez L, Escobar-Morreale HF.

    Lipoprotein subclasses compensate the classic atherogenic lipid profile of women with polycystic ovary syndrome, but common antiandrogenic treatments worsen their lipidome.

    EUROPEAN JOURNAL OF ENDOCRINOLOGY . 193(5): 595-605.

    [doi:10.1093/ejendo/lvaf213]

  • Luque-Ramírez M, Quintero-Tobar A, Martínez-García MÁ, de Lope Quiñones S, Insenser M, Nattero-Chávez L, Escobar-Morreale HF.

    Mild hyperprolactinemia in women with polycystic ovary syndrome. Insights from a large cross-sectional study.

    Journal Of Clinical & Translational Endocrinology . 41: 100412-100412.

    [doi:10.1016/j.jcte.2025.100412]

  • Chico A, Pazos-Couselo M, Nattero-Chavez L, Simó-Servat O, Durán-Martínez M, Ugarte-Abasolo E, Aguilera E, Andía V, Moreno-Fernández J, Granados M, Rebollo A, Fernandez-Rubio E, Quirós C, Alpañés M, Márquez R, Beato-Vibora P, Lado-Baleato O, Picón-César MJ.

    Beyond glycemic metrics: Real-world benefits of connected insulin pens in type 1 diabetes.

    DIABETES RESEARCH AND CLINICAL PRACTICE . 226: 112377-112377.

    [doi:10.1016/j.diabres.2025.112377]

  • Bayona Cebada A, Nattero-Chávez L, De la Calle De la Villa E, Quintero Tobar A, de Lope Quiñones S, Dorado Avendaño B, Fiers T, Kaufman JM, Luque-Ramírez M, Escobar-Morreale HF.

    Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes.

    Human Reproduction Open . 2025(3): .

    [doi:10.1093/hropen/hoaf048]

  • Giralt M, Ferrer R, Díaz-Troyano N, Vega B, Luque-Ramírez M, Martínez S, Fernández B, Martínez I, Fabregat A, Urgell E, Cardona I, Casals G, Escobar-Morreale HF.

    Analytical Interference of Exemestane With Androstenedione Immunoassays.

    ANN LAB MED . 45(4): 410-419.

    [doi:10.3343/alm.2024.0362]

  • Beato-Víbora PI, Chico A, Moreno-Fernandez J, Azriel-Mira S, Nattero-Chávez L, Mora RV, Alonso-Carril N, Simó-Servat O, Aguilera-Hurtado E, Reyes Céspedes LM, de Adana MR, Domínguez M, Márquez-Pardo R, Díaz-Soto G, Martínez-Brocca MA, Fernández KA, Buesa MA, Hernández MC, Quirós C.

    Transitioning between automated insulin delivery systems: A focus on personalisation.

    DIABETES RESEARCH AND CLINICAL PRACTICE . 222: 112070-112070.

    [doi:10.1016/j.diabres.2025.112070]

  • de Lope Quiñones S, Luque-Ramírez M, Michael Fernández AC, Quintero Tobar A, Quiñones-Silva J, Martínez García MÁ, Insenser Nieto M, Dorado Avendaño B, Escobar-Morreale HF, Nattero-Chávez L.

    Unveiling Silent Atherosclerosis in Type 1 Diabetes: The Role of Glycoprotein and Lipoprotein Lipidomics, and Cardiac Autonomic Neuropathy.

    Metabolites . 15(1): .

    [doi:10.3390/metabo15010055]

  • Nattero-Chávez L, de La Calle E, Lecumberri-Pascual E, Bayona Cebada A, Ruiz Gracia T, Quintero Tobar A, Lorenzo Moñino M, Sánchez Rodríguez C, Izquierdo A, Escobar-Morreale HF, Luque-Ramírez M.

    Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled clinical trial in patients with type 1 diabetes.

    Therapeutic Advances in Endocrinology and Metabolism . 15: .

    [doi:10.1177/20420188241288789]

  • Insenser MR, Nattero-Chávez L, Luque-Ramírez M, Quiñones SL, Quintero-Tobar A, Samino S, Amigó N, Dorado Avendaño B, Fiers T, Escobar-Morreale HF.

    Investigating the Link between Intermediate Metabolism, Sexual Dimorphism, and Cardiac Autonomic Dysfunction in Patients with Type 1 Diabetes.

    Metabolites . 14(8): .

    [doi:10.3390/metabo14080436]

  • Luque-Ramírez M, Martínez-García MÁ, Insenser M, Fernández-Durán E, Quintero-Tobar A, Fiers T, Kaufman JM, García-Cano AM, Rosillo Coronado M, Nattero-Chávez L, Escobar-Morreale HF.

    Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting.

    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION . : .

    [doi:10.1007/s40618-024-02416-0]

  • Martínez-García MÁ, Quintero-Tobar A, de Lope Quiñones S, Insenser M, Fernández-Durán E, Escobar-Morreale HF, Luque-Ramírez M.

    Obesity and polycystic ovary syndrome influence on intestinal permeability at fasting, and modify the effect of diverse macronutrients on the gut barrier.

    FOOD RESEARCH INTERNATIONAL . 186: 114338-114338.

    [doi:10.1016/j.foodres.2024.114338]

  • Rodriguez-Muñoz A, Motahari-Rad H, Martin-Chaves L, Benitez-Porres J, Rodriguez-Capitan J, Gonzalez-Jimenez A, Insenser M, Tinahones FJ, Murri M.

    A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle.

    Current obesity reports . 13(3): 403-438. Number of citations: 1

    [doi:10.1007/s13679-024-00561-4]

  • Beato-Víbora PI, Chico A, Moreno-Fernandez J, Bellido-Castañeda V, Nattero-Chávez L, Picón-César MJ, Martínez-Brocca MA, Giménez-Álvarez M, Aguilera-Hurtado E, Climent-Biescas E, Azriel-Mira S, Rebollo-Román Á, Yoldi-Vergara C, Pazos-Couselo M, Alonso-Carril N, Quirós C.

    Response to Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. Diabetes Care 2024;47:216-224.

    Diabetes Care . 47(5): 46-47.

    [doi:10.2337/dci24-0017]

  • Ramos Bachiller B, Luque-Ramírez M, Rodríguez-Jiménez C, Arrieta Blanco FJ.

    Familial ApoB-specific familial hypobetalipoproteinemia in a patient with non-classical congenital adrenal hyperplasia.

    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS . 36(3): 128-132.

    [doi:10.1016/j.arteri.2023.12.002]

  • Luque-Ramírez M, Nattero-Chávez L, Rodríguez-Rubio Corona C, Ortiz-Flores AE, García-Cano AM, Rosillo Coronado M, Pérez Mies B, Ruz Caracuel I, Escobar-Morreale HF.

    Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience.

    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION . 47(8): 2007-2020.

    [doi:10.1007/s40618-023-02297-9]

  • Nattero-Chávez L, Insenser M, Amigó N, Samino S, Martínez-Micaelo N, Dorado Avendaño B, Quintero Tobar A, Escobar-Morreale HF, Luque-Ramírez M.

    Quantification of lipoproteins by proton nuclear magnetic resonance spectroscopy ((1)H-NMRS) improves the prediction of cardiac autonomic dysfunction in patients with type 1 diabetes.

    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION . 47(8): 2075-2085. Number of citations: 1

    [doi:10.1007/s40618-023-02289-9]

  • Beato-Víbora PI, Chico A, Moreno-Fernandez J, Bellido-Castañeda V, Nattero-Chávez L, Picón-César MJ, Martínez-Brocca MA, Giménez-Álvarez M, Aguilera-Hurtado E, Climent-Biescas E, Azriel-Mir S, Rebollo-Román Á, Yoldi-Vergara C, Pazos-Couselo M, Alonso-Carril N, Quirós C.

    A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting.

    Diabetes Care . 47(2): 216-224. Number of citations: 33

    [doi:10.2337/dc23-1355]